Adrenal disease

Genetics and clinical characteristics of Korean patients with bilateral macronodular adrenocortical disease

Eur J EndocrinolPublished Retrospective cohort study

Authors' conclusion

This study in a Korean cohort with BMAD showed that P/LP ARMC5 variants were present in 22.9% of the genetically investigated patients and were associated with more severe radiological and steroidogenic features. These findings underscore the importance of closely monitoring patients with BMAD who carry ARMC5 P/LP variants.

Study context

Population
Korean patients with bilateral macronodular adrenocortical disease (BMAD), Seoul National University Hospital (2009–2023); mean age 66.4 years, 58% male35 had WES
Participants
69 patients
Exposure
P/LP ARMC5 variant carriers vs non-carriers
Outcome
Prevalence of pathogenic variants and genotype-phenotype correlations
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

P/LP ARMC5 variants among genetically tested patients

Harbored P/LP variants in ARMC5 (of 35 tested)

22.9%

Observational data: associations, not effects.

Further findings

Cortisol secretion phenotype

Mild autonomous cortisol secretion
79.7%
Overt Cushing syndrome
15.9%

Clinical and imaging features, carriers vs non-carriers

BMI lower in carriers
25.0 vs 27.4 kg/m²
Maximal tumour diameter larger in carriers
4.1 vs 2.7 cm
Total adrenal volume greater in carriers
19.8 vs 15.3 cm³

Serum steroids by LC-MS/MS, carriers vs non-carriers

Cortisol significantly higher in carriers
153.1 vs 100.6 ng/mL
Corticosterone significantly higher in carriers
16.5 vs 1.3 ng/mL
18-hydroxycortisol significantly higher in carriers
1.66 vs .66 ng/mL
  • P < .05

Original publication

Genetics and clinical characteristics of Korean patients with bilateral macronodular adrenocortical disease. Eur J Endocrinol. Published 19 January 2026. doi:10.1093/ejendo/lvag014

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.